What question did this study set out to answer?

The study aims to evaluate vaccination compliance among adults following HSCT for B-cell malignancies, comparing data against guidelines.

Vaccination Uptake in Adults Post‐Haematopoietic Stem Cell Transplantation for B‐Cell Malignancies

View Full Paper

Ask AI

Bookmark

Authors

Audit assesses vaccination compliance in adults post-HSCT, revealing significant gaps in uptake and completion rates.

The study aims to evaluate vaccination compliance among adults following HSCT for B-cell malignancies, comparing data against guidelines.
Identified patients through the Haematology Cancer Database who underwent HSCT with BEAM conditioning.
Collected retrospective data from digital health records on vaccination timelines and compliance.
Assessed patient demographics, vaccination commencement and completion rates, and adherence to vaccine protocol.
86.36% of patients commenced re-vaccination at 6 months post-HSCT.
Only 41% completed all recommended non-live vaccines by 24 months.
Uptake varied among vaccines, with the highest being Men ACWY at 79%, and the lowest for the second PPSV23 dose at 60%.
Immunosuppressive therapy and administrative gaps contributed to missed vaccinations.

Akram et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark